01-01-1970 12:00 AM | Source: Accord Fintech
Dr. Reddy`s Laboratories surges on reporting 75% rise in Q3 consolidated net profit
News By Tags | #180 #642 #1302 #572

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Dr. Reddy's Laboratories is currently trading at Rs. 4320.15, up by 115.60 points or 2.75% from its previous closing of Rs. 4204.55 on the BSE.

The scrip opened at Rs. 4293.35 and has touched a high and low of Rs. 4382.35 and Rs. 4265.30 respectively.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4,645.55 on 2-November-2022 and a 52 week low of Rs. 366.05 on 4-March-2022.

Last one week high and low of the scrip stood at Rs. 4400.00 and Rs. 4176.85 respectively.

The promoters holding in the company stood at 46.39%, while Institutions and Non-Institutions held 29.25% and 20.10% respectively.

Dr. Reddy's Laboratories has reported a fall of 4.84% in its net profit at Rs 324.60 crore for third quarter ended December 31, 2022 as compared to Rs 341.10 crore for the same quarter in the previous year. However, total income of the company increased 11.47% at Rs 3949.00 crore for Q3FY23 as compared to Rs 3542.60 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 75.37% in its net profit at Rs 1243.90 crore for third quarter ended December 31, 2022 as compared to Rs 709.30 crore for the same quarter in the previous year. Total income of the company increased 26.96% at Rs 6848.50 crore for Q3FY23 as compared to Rs 5394.10 crore for the corresponding quarter previous year